硫酸软骨素基生物相容性交联剂恢复角膜力学与胶原排列
在离体兔角膜模型中评估功能化硫酸软骨素(CS-NHS)的交联效果:CS-NHS在60分钟内渗透角膜基质,使肿胀率降低35%、杨氏模量增加20%,并增加胶原纤维直径和密度;在离体圆锥角膜(KC)样模型中,CS-NHS交联改善角膜力学至与核黄素-紫外线(UV)交联相当的水平,且促炎基因表达显著下调,表明CS-NHS可能提供有效、安全、生物相容的角膜加固手段。
要点
- CS-NHS在60分钟内有效渗透兔角膜基质,使肿胀率降低35%、杨氏模量增加20%。
- CS-NHS交联增加胶原纤维直径和密度,并改善KC模型角膜力学至与UV交联相当水平。
- CS-NHS交联显著下调角膜细胞促炎基因表达,未引起广泛角膜细胞凋亡。
核心结论
- CS-NHS可增强正常及KC模型角膜的力学性能,恢复KC模型角膜的胶原密度和排列,且不引起广泛角膜细胞凋亡和促炎基因上调。
- 因此,CS-NHS交联可能成为有效、安全且生物相容的角膜加固手段。
研究设计与样本
- 离体兔角膜模型实验:硫酸软骨素分子经N-羟基琥珀酰亚胺(NHS)基团化学修饰,使用2、5或10 mg/mL CS-NHS溶液交联离体兔眼30或60分钟。
- 另用胶原酶-软骨素酶溶液处理兔角膜建立离体圆锥角膜(KC)样模型,分别采用标准核黄素-紫外线(UV)交联或CS-NHS交联。
- 检测指标包括CS-NHS渗透性、角膜肿胀率、杨氏模量、超微结构及角膜细胞基因表达。
主要发现
- CS-NHS在治疗开始后60分钟内有效渗透至角膜基质。
- CS-NHS交联使肿胀率降低35%,杨氏模量增加20%,并增加胶原纤维直径和密度。
- CS-NHS交联将KC模型角膜力学改善至与UV交联相当的水平。
- CS-NHS交联显著下调角膜细胞促炎基因表达,提示CS-NHS在交联过程中可能具有保护作用。
关键数值与推荐
- CS-NHS溶液浓度:2、5或10 mg/mL;处理时间:30或60分钟。
- CS-NHS交联使肿胀率降低35%,杨氏模量增加20%。
- CS-NHS在60分钟内渗透至角膜基质。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the crosslinking effect of functionalized chondroitin sulfate (CS) in an ex vivo rabbit cornea model. METHODS: Chondroitin sulfate molecules were chemically modified with the N-hydroxysuccinimide (NHS) group. Enucleated rabbit eyes were crosslinked with 2, 5, or 10 mg/mL CS-NHS solution for 30 or 60 minutes. The CS-NHS penetration, corneal swelling ratio, Young's modulus, and ultrastructure of the crosslinked corneas were characterized. In addition, rabbit corneas were further treated with a collagenase-chondroitinase solution to create an ex vivo keratoconus (KC)-like model. The KC model corneas were crosslinked with a standard riboflavin-ultraviolet (UV) method or alternatively with CS-NHS. Corneal mechanics, ultrastructure, and keratocyte gene expression were evaluated after UV and CS-NHS crosslinking. RESULTS: CS-NHS effectively penetrated into the corneal stroma within 60 minutes of treatment initiation. CS-NHS crosslinking reduced the swelling ratio by 35%, increased Young's modulus by 20%, and increased collagen fibril diameter and density. CS-NHS crosslinking improved corneal mechanics of KC model corneas to levels comparable to those with UV crosslinking. Moreover, CS-NHS crosslinking demonstrated significant downregulation of proinflammatory gene expression of keratocytes, indicating a potential protective effect imparted by CS-NHS during crosslinking. CONCLUSIONS: Our results demonstrated that CS-NHS can reinforce normal and KC model corneal mechanics, and restore collagen density and alignment in KC model corneas without causing extensive keratocyte apoptosis and proinflammatory gene upregulation. Therefore, CS-NHS crosslinking can potentially provide an effective, safe, and biocompatible means of corneal reinforcement.
引用
- Wang X, Majumdar S, Ma G, et al. Chondroitin Sulfate-Based Biocompatible Crosslinker Restores Corneal Mechanics and Collagen Alignment. Invest Ophthalmol Vis Sci. 2017. PMID: 28763562. doi:10.1167/iovs.16-21292
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。